These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8241336)

  • 21. Pharmacokinetics of oral cephradine in continuous ambulatory peritoneal dialysis patients.
    Johnson CA; Welling PG; Zimmerman SW
    Nephron; 1984; 38(1):57-61. PubMed ID: 6472532
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peritonitis with continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis.
    Warady BA; Campoy SF; Gross SP; Sedman AB; Lum GM
    J Pediatr; 1984 Nov; 105(5):726-30. PubMed ID: 6502302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The response of human peritoneal macrophages to stimulation with bacteria isolated from episodes of continuous ambulatory peritoneal dialysis-related peritonitis.
    Mackenzie RK; Coles GA; Williams JD
    J Infect Dis; 1991 Apr; 163(4):837-42. PubMed ID: 1849163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro antistaphylococcal activity of teicoplanin and ciprofloxacin in peritoneal dialysis effluent.
    Guay D; Klicker R; Pence T; Peterson P
    Eur J Clin Microbiol; 1986 Dec; 5(6):661-3. PubMed ID: 2948820
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparison of peritoneal fluid culture results from adults and children undergoing CAPD.
    Yinnon AM; Gabay D; Raveh D; Schlesinger Y; Slotki I; Attias D; Rudensky B
    Perit Dial Int; 1999; 19(1):51-5. PubMed ID: 10201341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The epidermo-peritoneal potential in patients treated with continuous ambulatory peritoneal dialysis.
    Davenport A; Dealler SF
    Int J Artif Organs; 1993 Feb; 16(2):71-4. PubMed ID: 8486415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Streptococcal versus Staphylococcus epidermidis peritonitis in CAPD. A comparative study.
    Muñoz de Bustillo E; Aguilera A; Jiménez C; Bajo MA; Sánchez C; Selgas R
    Perit Dial Int; 1997; 17(4):392-5. PubMed ID: 9284469
    [No Abstract]   [Full Text] [Related]  

  • 28. Peritoneal fluid cell counts and cultures in CAPD patients receiving intraperitoneal streptokinase (urokinase) for relapsing peritonitis.
    Tzamaloukas AH
    Perit Dial Int; 1989; 9(2):143-4. PubMed ID: 2488202
    [No Abstract]   [Full Text] [Related]  

  • 29. Generalized lymphadenopathy in continuous ambulatory peritoneal dialysis patients associated with Staphylococcus epidermidis infection.
    Pollock CA; Ibels LS
    Nephron; 1989; 52(1):81-2. PubMed ID: 2710271
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Audit of infection in continuous ambulatory peritoneal dialysis.
    Wilson AP; Scott GM; Lewis C; Neild G; Rudge C
    J Hosp Infect; 1994 Dec; 28(4):265-71. PubMed ID: 7897188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reactive arthritis associated with Staphylococcus epidermidis peritonitis in patient undergoing continuous ambulatory peritoneal dialysis.
    Hughes BR; Hind CR
    Br Med J (Clin Res Ed); 1983 Jan; 286(6360):188-9. PubMed ID: 6401523
    [No Abstract]   [Full Text] [Related]  

  • 32. The significance of slime-producing coagulase-negative staphylococci in CAPD peritonitis.
    Melita-Manoli H; Vatopoulos A; Toutouza M; Drivas G; Katirtzoglou A
    Clin Nephrol; 1993 Feb; 39(2):111. PubMed ID: 8448913
    [No Abstract]   [Full Text] [Related]  

  • 33. [UV irradiation of the peritoneal dialysis solution for the prevention of peritonitis].
    Tolon M; Ohgke H; Botzenhart K; Sack K
    Klin Wochenschr; 1983 Nov; 61(22):1137-9. PubMed ID: 6418948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of resistance with heat-killed unencapsulated strains of Staphylococcus epidermidis against challenge with encapsulated strains of Staphylococcus epidermidis.
    Ichiman Y; Yamada T; Yoshida K
    Microbiol Immunol; 1989; 33(4):277-86. PubMed ID: 2770559
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peritonitis prevention in continuous ambulatory peritoneal dialysis.
    Luzar MA
    Nephrologie; 1992; 13(4):171-7. PubMed ID: 1407258
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The prevention of infection with Staphylococcus aureus in continuous ambulatory peritoneal dialysis.
    Ludlam H; McCann M
    J Hosp Infect; 1991 Apr; 17(4):324-6. PubMed ID: 1677667
    [No Abstract]   [Full Text] [Related]  

  • 37. Vaccination for prevention of CAPD associated staphylococcal infection: results of a prospective multicentre clinical trial.
    Poole-Warren LA; Hallett MD; Hone PW; Burden SH; Farrell PC
    Clin Nephrol; 1991 May; 35(5):198-206. PubMed ID: 1855327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment with intravenous daptomycin for a peritonitis relapse caused by Staphylococcus epidermidis.
    Levy F; Camarero Temiño V; Blasco Mollá A; Ortega Lafont MP; Abaigar Luquin P; Izquierdo Ortiz MJ; Torres Torres G
    Nefrologia; 2011; 31(3):374-5. PubMed ID: 21629350
    [No Abstract]   [Full Text] [Related]  

  • 39. Peritonitis in children undergoing continuous ambulatory peritoneal dialysis.
    Fine RN; Salusky IB; Hall T; Lucullo L; Jordan SC; Ettenger RB
    Pediatrics; 1983 May; 71(5):806-9. PubMed ID: 6835766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of infection rates among older and younger patients on continuous peritoneal dialysis.
    Holley JL; Bernardini J; Perlmutter JA; Piraino B
    Perit Dial Int; 1994; 14(1):66-9. PubMed ID: 8312418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.